title: Protective effect of methylprednisolone on vascular injury in rat spinal cord injury.
abstract: High-dose methylprednisolone (MP) given to patients within 8 h of traumatic spinal cord improved neural function at 6 and 12 months, suggesting a probable secondary injury process that may be amenable to therapeutic intervention. Vascular injury plays an important role in the secondary injury process of CNS trauma. We have examined the effect of MP on vascular changes, including tissue edema, vascular permeability, and polymorphonuclear (PMN) cell infiltration in a rat model of spinal cord impact injury. MP significantly reduced extravasation of fluorescein isothiocyanate dextran (FITC-D), a macromolecular tracer, by 64.3% and 50.7% with trauma forces of 20 and 40 g-cm, respectively, when MP was administered IV immediately after trauma at a bolus of 165 mg/kg, with a subsequent continuous MP infusion at 31.5 mg/kg/h for 23 h. MP reduced the water content in the 40 g-cm traumatic cord lesion to 73.0% compared to the traumatic control (74.3%, p < 0.001) at the same schedule of large dose 24-h infusion. The same doses of MP showed a trend to decrease the extent of neutrophil infiltration as determined by myeloperoxidase (MPO) activity, but the change was not significant. MP had little effect in decreasing FITC-D extravasation and cord edema when given at a lower dose (bolus of 30 mg/kg with continued infusion of 1.3 mg/kg/h for 23 h). MP did not reduce extravasation of FITC-D and edema when administered IV as one bolus injection at high (165 mg/kg) or low (30 mg/kg) doses.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Neurology, Medical University of South Carolina, Charleston.
authors.forename: J
authors.initials: J
authors.lastname: Xu
authors.forename: Z X
authors.initials: ZX
authors.lastname: Qu
authors.forename: E L
authors.initials: EL
authors.lastname: Hogan
authors.forename: P L
authors.initials: PL
authors.lastname: Perot
mesh_terms: D000818:Animals; D001808:Blood Vessels / Q000293:injuries* / Q000473:pathology; D002199:Capillary Permeability / Q000187:drug effects; D004487:Edema / Q000473:pathology / Q000517:prevention & control; D008775:Methylprednisolone / Q000627:therapeutic use*; D009504:Neutrophils / Q000502:physiology; D009195:Peroxidase / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013119:Spinal Cord Injuries / Q000150:complications* / Q000201:enzymology / Q000503:physiopathology
chemical_list: D009195:Peroxidase; D008775:Methylprednisolone